A Study Looking at Women's Experiences After a Miscarriage

Miscarriage Clinical Trial

Official title:

An Investigation of Women's Experiences Following Karyotyping Products of Conception After a Miscarriage

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01223482
• Other study ID #: 1011-017
• Status: Recruiting
• Phase: N/A
• First received: October 18, 2010
• Last updated: December 16, 2010
• Start date: October 2010
• Est. completion date: June 2011

Study information

• Verified date: September 2010
• Source: California State University, Stanislaus
• Contact: Diem T Huynh, B.S.
• Phone: 650-483-5827
• Email: diem218[@]gmail.com
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Studies have shown that a majority of pregnancies that end in miscarriage are due to a chromosome abnormality usually involving a duplicated or missing chromosome. Often this happens by chance and is not likely to occur in future pregnancies. For many women, a miscarriage can be a traumatic experience and can cause feelings of loss and grief. The option of genetic testing, such as karyotyping, may offer an explanation for the miscarriage and may help some women find closure in their loss. However, no literature exists on a women's experience with genetic testing following a miscarriage. This assumption that the knowledge that can be gained from karyotyping may be a positive experience for a woman following a miscarriage should be studied and the results published. This study will address whether routine karyotyping should be offered following a miscarriage for the purpose of benefiting the patient's experience.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 400
• Est. completion date: June 2011
• Est. primary completion date: February 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• The inclusion criteria for this project will be females, 18 years or older, of any ethnicity that have had a 1st trimester miscarriage within the last one year, who currently reside in the US and have done so for the past one year.

Exclusion Criteria:

• Exclusion criteria will be males, females younger than 18 years of age, females with a miscarriage over one year, non-US residents and US residents where the miscarriage occurred outside of the US.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Abortion, Spontaneous
• Miscarriage

Locations

Country	Name	City	State
United States	Http://Www.Surveymonkey.Com/S/Miscarriagestudy3	Palo Alto	California

Sponsors (2)

Lead Sponsor	Collaborator
California State University, Stanislaus	Stanford University

Country where clinical trial is conducted

United States,